Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

1 Stock Under $50 with Exciting Potential and 2 We Brush Off

December 11, 2025

Hims & Hers Brings Comprehensive Weight Loss Programme to the UK

December 10, 2025

From Hims & Hers

5 High Short-Interest Stocks to Buy Before Q1 2026 ↗

December 09, 2025

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.

From Hype to P&L: Hospitals Now Buying AI That Pays

December 08, 2025

From USA News Group

Via GlobeNewswire

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

December 04, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Hims & Hers Continues Major International Expansion With Official Entry Into Canada

December 04, 2025

From Hims & Hers

Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology

December 03, 2025

From Hims & Hers

The healthcare industry is ripe for disruption.

Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip? ↗

November 26, 2025

Via The Motley Fool

Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗

November 25, 2025

Users pointed to emerging drug pipelines, GLP-1 expansion and rising M&A pressure across the sector.

Via Stocktwits

Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗

November 24, 2025

Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Topics Economy

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

November 23, 2025

MarketBeat Week in Review – 11/17 - 11/21 ↗

November 22, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky

November 21, 2025

KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds

November 20, 2025

KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a...

Via MarketMinute

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4.9% in the afternoon session after news of increased competition in the weight-loss drug market overshadowed the company’s own positive...

Ready For A Rebound? Here Are 10 Oversold Stocks To Watch ↗

November 17, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

November 17, 2025

Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from the company.

What's Going On With Hims & Hers Health Shares Monday? ↗

November 17, 2025

Via Benzinga

Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock ↗

November 17, 2025

The latest buyback program follows a $100 million share buyback program in July 2024, which has now been completed.

Via Stocktwits

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization

November 17, 2025

From Hims & Hers

Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

November 17, 2025

From Hims & Hers

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗

November 14, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds

November 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Hims & Hers Stock Logs 3-Day Losing Streak As Truist Calls Out Klarna GLP-1 Changes — Retail Sees Fresh Buy Zone ↗

Topics Stocks

November 13, 2025

Truist pointed to updated GLP-1 intake features, including Klarna financing, shorter shipping intervals and new semaglutide microdosing options.

Via Stocktwits

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks ↗

November 13, 2025

Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.

Via Benzinga

Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys

November 13, 2025

From Hims & Hers